Skip to main content
. 2021 Feb 8;10(2):261. doi: 10.3390/antiox10020261
ALA alpha-lipoic acid
ALT alanine transaminase
AST aspartate transaminase
AP-1 activator protein 1
CAMP cathelicidin antimicrobial peptide
CAT catalase
CCL chemokine motif ligand
CML carboxymethylisine
COPD chronic obstructive pulmonary disease
CoQ Coenzyme Q
COXs cyclooxygenases
DAMPS damage-associated molecular patterns
DM diabetes mellitus
DNA deoxyribonucleic acid
EDSS expanded disability status scale
ENA European Nutraceutical Association
FeNO fractional exhaled nitric oxide
FRAP Ferric reducing antioxidant power
FSP fermented soy permeate
GPx glutathione peroxidase
GSH glutathione
H2O2 hydrogen peroxide
hBD human beta defensin
HDL high-density liprotein
Hs-CRP high sensitivity-C-reactive protein
IGF insulin-like growth factor
IL interleukin
iNOS inducible nitric oxide synthase
IFN interferon
IP-10/CXCL10 induced protein-10/ C-X-C motif chemokine ligand 10
IU international unit
LDL low density lipoprotein
MA microalbuminuria
MCP-1 monocyte chemoattractant protein-1
MDA malondialdehyde
MIG monokine induced by gamma interferon
MIP macrophage inflammatory protein
MMP-3 matrix metalloproteinase-3.
Mn manganese
MOE methanolic oregano extract
MPO myeloperoxidase
MS multiple sclerosis
NAFLD nonalcoholic fatty liver disease
NK natural killer
NLRP3 NLR family pyrin domain containing 3
NO nitric oxide
NO2 nitrogen dioxide
NF-kB nuclear factor kappa B
RA rheumatoid arthritis
RANTES Regulated upon Activation, Normal T Cell Expressed and Presumably Secreted
ROS reactive oxygen species
SLE systemic lupus erythematosus
SOD superoxide dismutase
TAC total antioxidant capacity
TAS total antioxidative status
Th T helper
TNF-ɑ tumor necrosis factor-alpha
TXNIP thioredoxin-interacting protein
VEC vitamin E content
VEGF vascular endothelial growth factor
WBCT whole-body cryotherapy treatment